Evidence map›Paper›PMID 31089181›Full record

ArticleScientific reports2019

Structure and tailspike glycosidase machinery of ORF212 from E. coli O157:H7 phage CBA120 (TSP3).

Julia Greenfield, Xiaoran Shang, Heng Luo, Yan Zhou, Ryan D Heselpoth, Daniel C Nelson, Osnat Herzberg

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Viruses · 2025
    Article
  5. Review
  6. Comprehensive Approaches to CombattingAntibiotics (Basel, Switzerland) · 2024
    Review
  7. Review
  8. Article
  9. Article
  10. Insights into theInternational journal of molecular sciences · 2023
    Article
  11. Article
  12. Article
  13. Prophage-Derived Regions inInternational journal of molecular sciences · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Julia GreenfieldInstitute for Bioscience and Biotechnology Research, University of Maryland, Rockville, Maryland, USA.
Xiaoran ShangInstitute for Bioscience and Biotechnology Research, University of Maryland, Rockville, Maryland, USA.
Heng LuoInstitute for Bioscience and Biotechnology Research, University of Maryland, Rockville, Maryland, USA.
Yan ZhouInstitute for Bioscience and Biotechnology Research, University of Maryland, Rockville, Maryland, USA.
Ryan D HeselpothInstitute for Bioscience and Biotechnology Research, University of Maryland, Rockville, Maryland, USA.
Daniel C NelsonInstitute for Bioscience and Biotechnology Research, University of Maryland, Rockville, Maryland, USA. nelsond@umd.edu.
Osnat HerzbergInstitute for Bioscience and Biotechnology Research, University of Maryland, Rockville, Maryland, USA. osnat@umd.edu.
Institute for Bioscience and Biotechnology ResearchAdvanced Bioscience Laboratories (United States) · USUniversity of Maryland, College Park · US

Funding

Structure, Function, and Engineering of Myovirus Phage CBA120 Tailspike ProteinsR01GM110202 · NIGMS · UNIV OF MARYLAND, COLLEGE PARK · PI NELSON, DANIEL C. · 2015 to 2019
$1.5M
NIGMS NIH HHS R01 GM110202U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R01GM110202
6 · The paper itself

Abstract

Bacteriophage tailspike proteins mediate virion absorption through reversible primary receptor binding, followed by lipopolysaccharide or exopolysaccharide degradation. The Escherichia coli O157:H7 bacteriophage CBA120 genome encodes four distinct tailspike proteins, annotated as ORFs 210 through 213. Previously, we reported the crystal structure of ORF210 (TSP1). Here we describe the crystal structure of ORF212 (TSP3) determined at 1.85 Å resolution. As observed with other tailspike proteins, TSP3 assembles into a trimer. Each subunit of TSP3 has an N-terminal head domain that is structurally similar to that of TSP1, consistent with their high amino acid sequence identity. In contrast, despite sharing a β-helix fold, the overall structure of the C-terminal catalytic domain of TSP3 is quite different when compared to TSP1. The TSP3 structure suggests that the glycosidase active site resides in a cleft at the interface between two adjacent subunits where three acidic residues, Glu362 and Asp383 on one subunit, and Asp426 on a second subunit, are located in close proximity. Comparing the glycosidase activity of wild-type TSP3 to various point mutants revealed that catalysis requires the carboxyl groups of Glu362 and Asp426, and not of Asp383, confirming the enzyme employs two carboxyl groups to degrade lippopolysaccharide using an acid/base mechanism.

Indexed as

BacteriophagesCatalytic DomainCrystallography, X-RayEnzyme StabilityEscherichia coli InfectionsEscherichia coli O157Glycoside HydrolasesHumansModels, MolecularProtein ConformationViral Tail ProteinsGlycoside Hydrolasestailspike protein, bacteriophageViral Tail Proteins

Identifiers

PMID31089181
PMCPMC6517402
OpenAlexW2946145217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.